ライフサイエンスコーパス: Candida parapsilosis

1 OLE1 on the emerging human pathogenic fungus Candida parapsilosis.

2 been grouped with the more prevalent species Candida parapsilosis.

3 te was Candida albicans, and one isolate was Candida parapsilosis.

4 andida guilliermondii, Candida glabrata, and Candida parapsilosis.

5 Doogh including Rhodotorula mucilaginosa and Candida parapsilosis.

6 stribution was 55.6% Candida albicans, 14.4% Candida parapsilosis, 13.4% Candida glabrata, 10.1% Cand

7 42 Candida albicans, 25 Candida glabrata, 22 Candida parapsilosis, 14 Candida tropicalis, and 8 Candi

8 a albicans, followed by Candida glabrata and Candida parapsilosis (15%), Candida tropicalis (9%), and

9 s (38%), followed by Candida glabrata (29%), Candida parapsilosis (17%), and Candida tropicalis (10%)

10 icans (0.4%), Candida tropicalis (1.3%), and Candida parapsilosis (2.1%); however, 8.8% of C. glabrat

11 ates was as follows: Candida albicans (52%), Candida parapsilosis (23.7%), Candida glabrata (12.7%),

12 pp identified were Candida albicans (55.8%), Candida parapsilosis (29.4%), Candida glabrata (7.8%), a

13 isolates of Candida albicans, 9 isolates of Candida parapsilosis, 5 isolates of Candida krusei, 3 is

14 es were Candida albicans (21 of 34 [62%]) or Candida parapsilosis (7 of 34 [29%]).

15 41 Candida albicans, 23 Candida glabrata, 20 Candida parapsilosis, 9 Candida tropicalis, and 1 each o

16 However, antibiotics promoted emergence of Candida parapsilosis, a collagenase-producing microorgan

17 ly related clade, Lodderomyces elongisporus, Candida parapsilosis, a new Candida sp., C. sojae, C. tr

18 n health care settings compared with that of Candida parapsilosis, a species known to colonize the sk

19 Candida parapsilosis accounts for a significant number o

20 However, we found that the linear mtDNA of Candida parapsilosis also employs recombination for repl

21 ds towards Candida albicans, Candida krusei, Candida parapsilosis and Cryptococcus neoformans were in

22 al characterizations of Est3 homologues from Candida parapsilosis and Lodderomyces elongisporus, whic

23 Candida krusei, 10 Candida dubliniensis, 10 Candida parapsilosis, and 10 Cryptococcus neoformans iso

24 Sixty isolates (44 Candida albicans, 12 Candida parapsilosis, and 4 Candida tropicalis isolates)

25 uding 28 (66.7%) Candida albicans, 8 (19.0%) Candida parapsilosis, and 5 (11.9%) Candida tropicalis i

26 tropicalis, 99.3% (95% CI, 98.7%-99.6%) for Candida parapsilosis, and 99.9% (95% CI, 99.7%-100.0%) f

27 nce is a concern for Nakaseomyces glabratus, Candida parapsilosis, and Candida auris and less so in C

28 solates of Candida glabrata, two isolates of Candida parapsilosis, and one isolate of Saccharomyces c

29 ecies of Candida albicans, Candida glabrata, Candida parapsilosis, Aspergillus fumigatus, and Aspergi

30 ata to propose zone size limits for tests of Candida parapsilosis ATCC 22019 (22 to 33 mm), C. tropic

31 ata to propose zone size limits for tests of Candida parapsilosis ATCC 22019 (28 to 37 mm), Candida a

32 proposed range for the suggested QC strains Candida parapsilosis ATCC 22019 and Candida krusei ATCC

33 ns isolates and two quality control strains (Candida parapsilosis ATCC 22019 and Candida krusei ATCC

34 mphotericin B, fluconazole, and flucytosine (Candida parapsilosis ATCC 22019 and Candida krusei ATCC

35 Two QC strains, Candida parapsilosis ATCC 22019 and Candida krusei ATCC

36 ns ATCC 90028, Candida krusei ATCC 6258, and Candida parapsilosis ATCC 22019.

37 ms and the cell viability of C. albicans and Candida parapsilosis biofilms in vitro.

38 Antifungal susceptibility testing among 1740 Candida parapsilosis blood isolates submitted to a Unite

39 regarding the optimal antifungal regimen for Candida parapsilosis bloodstream infection (BSI) in view

40 ality and 1-year recurrence in patients with Candida parapsilosis bloodstream infections (BSI).

41 Ten yeast bloodstream isolates identified as Candida parapsilosis by conventional methods grew as tur

42 trazolium metabolism in Candida albicans and Candida parapsilosis by using XTT [2,3-bis (2-methoxy-4-

43 aureus), Candida albicans (C. albicans) and Candida parapsilosis (C. parapsilosis) was investigated.

44 y identify Candida albicans, Candida krusei, Candida parapsilosis, Candida glabrata, and Candida trop

45 s, Streptococcus mutans, Candida tropicalis, Candida parapsilosis, Candida krusei, Candida glabrata,

46 non-Candida albicans Candida spp. (including Candida parapsilosis, Candida krusei, Candida guilliermo

47 icans, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida lusitaniae, Candida guilli

48 identify Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Aspergillu

49 tible in Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida kr

50 0543, Torulaspora delbrueckii CCMA 0684, and Candida parapsilosis CCMA 0544) singly and with co-inocu

51 positivity (n = 53) and stable expansion of Candida parapsilosis complex species (n = 19).

52 l genes within the genetically heterogeneous Candida parapsilosis complex.

53 Candida albicans, Candida glabrata, and Candida parapsilosis endophthalmitis isolates were each

54 ramers, the mtSSBs from Candida albicans and Candida parapsilosis formed stable homodimers.

55 phic and temporal trends in the isolation of Candida parapsilosis from clinical specimens and the in

56 lated Candida sojae, Candida viswanathii and Candida parapsilosis indicates loss of ancestral HIR-ass

57 Candida parapsilosis infection was associated with bette

58 Candida parapsilosis is a common cause of invasive candi

59 Candida parapsilosis is a frequent cause of disseminated

60 Candida parapsilosis is a major cause of human disease,

61 (S)-carbonyl reductase II (SCRII) from Candida parapsilosis is a short-chain alcohol dehydrogen

62 Candida parapsilosis is an important cause of bloodstrea

63 Candida parapsilosis is one of the most commen causes of

64 Candida parapsilosis is the third most frequent cause of

65 sitive with AF only (two C. albicans and one Candida parapsilosis isolate); and 13 were positive with

66 Rezafungin inhibited 99.6% of Candida parapsilosis isolates (MIC(50)/MIC(90), 1/2 mg/L

67 isteria monocytogenes, Candida albicans, and Candida parapsilosis isolates were detected in volumes a

68 isolates, 70 Candida tropicalis isolates, 36 Candida parapsilosis isolates, 13 isolates of other Cand

69 s a sequence derived from the extreme end of Candida parapsilosis linear mtDNA, and sequence analysis

70 We demonstrate a novel mechanism for Candida parapsilosis-mediated induction of IL-27 in a TL

71 Organisms in the latter group comprised Candida parapsilosis (n = 1), Candida tropicalis (n = 1)

72 brata (n = 41), Candida tropicalis (n = 35), Candida parapsilosis (n = 29), Candida krusei (n = 32),

73 icans (n = 420), Candida glabrata (n = 112), Candida parapsilosis (n = 30), Candida krusei (n = 12),

74 ans (n = 85), Candida glabrata (n = 63), and Candida parapsilosis (n = 44).

75 brata (n = 96), Candida tropicalis (n = 51), Candida parapsilosis (n = 47), Candida krusei (n = 11),

76 fied as Candida dubliniensis, one isolate of Candida parapsilosis (n = 73) identified as Candida pell

77 one Candida membranaefaciens (identified as Candida parapsilosis), one Candida norvegensis (identifi

78 telomeres identified in three yeast species, Candida parapsilosis, Pichia philodendra and Candida sal

79 roperties of 14 isolates of the form species Candida parapsilosis representing three diverse genetic

80 In this study, we analyzed the role of Candida parapsilosis-secreted aspartyl proteinase isoenz

81 Candida parapsilosis sensu stricto, C. orthopsilosis, an

82 estion of how the unit sized linear mtDNA of Candida parapsilosis terminating at both ends with array

83 The strains Candida parapsilosis, Torulaspora delbrueckii and Pichia

84 Candida dubliniensis with all agents and for Candida parapsilosis when caspofungin or micafungin but